Notice of Annual General Meeting in CellaVision AB, April 24, 2013

2013-03-21 - English

The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on April 24, 2013 at 16.00 at CellaVision AB, Scheelevägen 19 A, Ideon, in Lund, Sweden.

The complete notice is available in Swedish only, please click the link below.

For more information, please contact:
Yvonne Mårtensson, CEO. Phone: +46 708 33 77 82
e-mail: yvonne.martensson@cellavision.com

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In most countries sales are via global partners. Products are sold directly in the Nordic countries and via subsidiaries in the US, Canada and Japan. In 2012 sales were SEK 170 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com.  

PDF version: Notice of AGM in CellaVision AB, April 24, 2013 (in Swedish)

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analyst

ABG Sundal Collier AB
Sten Gustafsson
+46 8 566 286 93

Pareto Securities AB
Christian Lee
+46 8 402 52 67

 

Access our Student Resources

To access this resource, please provide the following information about yourself.